Elsevier

Annals of Oncology

Volume 29, Issue 2, February 2018, Page 523
Annals of Oncology

Corrigenda
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

https://doi.org/10.1093/annonc/mdx058
Under an Elsevier user license
open archive

Cited by (0)